214 products newly listed to NHI reimbursement book.

Published: 2006-04-20 06:56:00

Updated: 2006-04-20 06:56:00

214 drugs including Yuhan's Gabaact 600mg tab. and Dongwha's Itopid tab. were approved to reimburse by the NHI plan, and the upper limit prices of 10 drugs including Hanmi's Levoxacin altered according to the MOHW announcement on April 14 under "List of NHI reimbursable and non-reimbursable drugs...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK